QDx Malaria

Nearly half of the world's population was at risk of malaria. Some population groups are at considerably higher risk of contracting malaria, and developing severe disease, than others. These include infants, children under 5 years of age, pregnant women and patients with HIV/AIDS, as well as non-immune migrants, mobile populations and travellers. Early diagnosis and treatment of malaria should take place within 24 h of the onset of symptoms. However, delay in malaria diagnosis and treatment is a major problem. QDx Malaria test can help clinicians to reduce the risk caused by malarial parasite by quickly diagnosing the type of infection followed by immediate treatment.

read more (QDx Malaria Pv/Pf)

read more (QDx Malaria PAN/Pf)

QDx Vit. D

Vitamin D deficiency is quite widespread; Awareness and, therefore, the demand for Vitamin D supplements is growing day by day. QDx Vit. D helps the physician screen the Vitamin D levels of the patient on the spot for immediate decision and treatment. QDx Vit. D is a unique, patented product for easy determination of vitamin D levels. Useful test for clinician’s chamber for making quick decision and immediate treatment for patient.

read more

QDx TropI

A heart attack is a medical emergency and can be life threatening. Acting fast at the first sign of heart attack symptoms can save your life and limit damage to your heart. Not all heart attacks begin with the sudden, crushing chest pain or other common symptoms such as chest discomfort. The symptoms of a heart attack can vary from person to person.

The key to saving lives in heart attack scenarios is time and the quicker and more accurate the diagnosis can be made, the faster proper care and treatment can be instituted.

QDx TropI is qualitative test that aids in diagnosis of acute myocardial infarction (AMI) useful in emergencies or ambulance services for diagnosis of MI in the suspected cases of cardiac attack. 

read more

QDx Malaria PAN/Pf

Rapid test for detection of all species of malaria and differential detection of Plasmodium falciparum.
Unique double antigen detecting assay with monoclonal anti HRP-2 (Pf Specific) and monoclonal anti pLDH (PAN specific) antibodies coated on test lines, confirming positive test results.
Provision to diagnose P. ovale, P. malariae, P. vivax due to application of monoclonal anti pLDH (PAN specific) on PAN test line.

read more 

QDx Dengue Combo

Efficient and accurate diagnosis of dengue is of primary importance for clinical care. Dengue virus infection produces a broad spectrum of symptoms, many of which are non-specific. Thus, a diagnosis based only on clinical symptoms is unreliable. After the onset of illness, the virus can be detected in serum, plasma, circulating blood cells and other tissues for 4–5 days using various method. Antibody response to infection differs according to the immune status of the host The patients develop a primary antibody response characterized by a slow increase of specific antibodies. IgM antibodies are the first immunoglobulin isotype to appear. These antibodies are detectable in 50% of patients by days 3-5 after onset of illness. Anti-dengue serum IgG is generally detectable at the end of the first week of illness, increasing slowly thereafter and develops memory cells. Early laboratory confirmation of clinical diagnosis may be valuable because some patients progress over a short period from mild to severe disease and sometimes to death. Early intervention may be life-saving. QDx Dengue Combo is qualitative test for differential diagnosis of early, critical and past infection due to dengue virus using NS1 antigen and IgG/IgM antibody. 

read more

QDx S typhi IgG/IgM

Typhoid fever caused by Salmonella typhi continues to be a major public health problem in developing countries. Accurate diagnosis of typhoid fever at and early stage is not only important for etiological diagnosis but to identify, treat the potential carriers and prevent acute typhoid fever outbreaks. The conventional WIDAL test usually detects antibodies to Salmonella typhi in the patient sample from the second week of the onset of symptoms. However the detection may be earlier if specific IgM antibodies are detected IgG and IgM or both IgG/ IgM.

read more